Catheter Precision Converts Series A Preferred Stock
Company Announcements

Catheter Precision Converts Series A Preferred Stock

An update from Catheter Precision (VTAK) is now available.

On July 24, 2024, a company successfully converted all outstanding Series A Convertible Preferred Stock into 25,000 shares of common stock, with the event taking place the previous day. This conversion, exempt from commission charges under a specific securities act provision, led to the registration of the new common stock for resale. Consequently, no Series A Preferred shares remain outstanding following this transaction.

Learn more about VTAK stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyCatheter Precision reports Q3 revenue $96,000
TheFlyCatheter Precision presents clinical data from VIVO EU Registry
TheFlyCatheter Precision announces exercise of warrants for $4.9M in gross proceeds
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App